| Current Price | $50.03 | Mkt Cap | $1.1B |
|---|---|---|---|
| Open | $49.97 | P/E Ratio | 39.82 |
| Prev. Close | $50.03 | Div. (Yield) | $0.56 (1.1%) |
| Daily Range | $49.84 - $50.67 | Volume | 48,122 |
| 52-Wk Range | $38.32 - $56.38 | Avg. Daily Vol. | 92,575 |
The Company is a medical device company that develops, manufactures and markets medical devices for the treatment of peripheral vascular disease.
| Current Price | $50.03 | Mkt Cap | $1.1B |
|---|---|---|---|
| Open | $49.97 | P/E Ratio | 39.82 |
| Prev. Close | $50.03 | Div. (Yield) | $0.56 (1.1%) |
| Daily Range | $49.84 - $50.67 | Volume | 48,122 |
| 52-Wk Range | $38.32 - $56.38 | Avg. Daily Vol. | 92,575 |
The best Bull and Bear pitches based on recency and number of recommendations.
Hidden gem in healthcare equipment. Focuses on niche products that large companies would not care about. Steadily introduces new products through R&D and has steady acquisitions. They are also debt free, so recession shouldn't hurt them.
There are no pitches that meet the Top Bear criteria. Explain
If this upsets you, start recommending pitches below!
Read the most recent pitches from players about LMAT.
Recs
LazyHarlequin
(92.86)
Submitted: 10/5/2018 10:13:42 AM :
Start Price:
$28.39
NASDAQ:LMAT Score:
-40.31
ON 10/5/18 down $6.13 to $29.83. Options available.
Recs
ATrain
(36.80)
Submitted: 10/3/2017 6:35:53 PM :
Start Price:
$35.67
NASDAQ:LMAT Score:
-15.34
Hidden gem in healthcare equipment. Focuses on niche products that large companies would not care about. Steadily introduces new products through R&D and has steady acquisitions. They are also debt free, so recession shouldn't hurt them.
Recs
TMFEBCapital
(76.92)
Submitted: 7/10/2017 2:24:24 PM :
Start Price:
$26.46
NASDAQ:LMAT Score:
+27.00
Small cap, debt-free company growing top-line 10%, bottom-line 20%, by targeting niche vascular surgery products, including biologics. 18% owned by founder aligns perfectly with investors. Tailwinds due to aging baby boomers support U.S. revenue, where margins are best. Company has not relied on price increases for growth (<5% annually). Using weakness on downgrades today to add.
Find the members with the highest scoring picks in LMAT.
roosterus (< 20) Score: +615.33
The Score Leader is the player with the highest score across all their picks in LMAT.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| roosterus | < 20 | 9/24/2007 |
|
3W | $5.64 | +787.06% | +171.72% | +615.33 | 0 Comment | |
| razormd | 83.05 | 9/24/2007 |
|
5Y | $5.74 | +771.03% | +170.62% | +600.41 | 1 Comment | |
| swr1111 | < 20 | 12/6/2007 |
|
NS | $5.80 | +763.14% | +177.12% | +586.01 | 1 Comment | |
| lionstan | 89.80 | 9/25/2007 |
|
5Y | $5.86 | +754.19% | +172.27% | +581.92 | 0 Comment | |
| Schneezy | 28.03 | 10/25/2010 |
|
1Y | $5.60 | +792.98% | +229.98% | +563.00 | 0 Comment | |
| pituach | < 20 | 10/9/2007 |
|
NS | $6.15 | +713.22% | +165.17% | +548.05 | 0 Comment | |
| MooFoo | < 20 | 10/28/2013 |
|
5Y | $6.85 | +630.26% | +123.51% | +506.74 | 0 Comment | |
| italianBull | < 20 | 11/26/2007 |
|
3W | $6.39 | +683.42% | +185.19% | +498.23 | 0 Comment | |
| orobica | 30.61 | 7/25/2014 |
|
5Y | $7.27 | +588.57% | +98.78% | +489.79 | 0 Comment | |
| Playa14 | < 20 |
|
|
5Y | $7.32 | +583.82% | +96.56% | +487.26 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
